Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.73 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | WRN | Q14191 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50185 | 0.94 | NAAA (0.81) | NAAAHTTDGKAALDH1A1GAA | |
| SCHEMBL28312766 | 0.92 | NAAA (0.64) | NAAAHTTDGKAALDH1A1GAA | |
| SCHEMBL14472850 | 0.92 | NAAA (0.86) | NAAAHTTDGKARAD52NPSR1 | |
| SCHEMBL3993048 | 0.92 | NAAA (0.86) | NAAAHTTDGKARAD52NPSR1 | |
| SCHEMBL12956536 | 0.92 | NAAA (0.86) | NAAAHTTDGKARAD52NPSR1 | |
| SCHEMBL14944491 | 0.90 | ALDH1A1 (0.62) | NAAAHTTDGKAALDH1A1GAA | |
| SCHEMBL448874 | 0.90 | NAAA (0.61) | NAAAHTTDGKAALDH1A1GAA | |
| SCHEMBL28562463 | 0.89 | NAAA (0.82) | NAAAHTTDGKAALDH1A1RAD52 | |
| SCHEMBL26794 | 0.89 | — | — | |
| SCHEMBL445680 | 0.88 | NAAA (0.59) | NAAAHTTDGKAALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102738508-A | Lithium ion battery electrolyte with low lithium salt content | INST PROCESS ENG CAS | 2012-10-17 | — | — | CN | claimed |
| CN-102195091-A | Ionic liquid electrolyte for lithium secondary battery | INST PROCESS ENG CAS | 2011-09-21 | — | — | CN | claimed |
| CN-102171228-A | Method for producing mono-hydroxy-functionalized dialkylphosphinic acids, esters and salts by means of vinyl esters of carboxylic acids and use thereof | CLARIANT INT LTD | 2011-08-31 | — | — | CN | claimed |
| CN-102171227-A | Method for producing mono-carboxy-functionalized dialkylphosphinic acids, esters and salts using a vinyl ester of a carboxylic acid and the use thereof | CLARIANT INT LTD | 2011-08-31 | — | — | CN | claimed |
| CN-101602834-B | Preparation method of polycarboxylic acid concrete dispersers | JIANGSU SUBOTE MATERIAL CO LTD | 2010-12-29 | — | — | CN | claimed |
| CN-101602834-A | A kind of preparation method of polycarboxylic acid concrete dispersers | JIANGSU SUBOTE MATERIAL CO LTD (CN) | 2009-12-16 | — | — | CN | claimed |
| CN-101425610-A | Alkylthiophene ionic liquid electrolysis solution used for lithium secondary battery | UNIV SHANGHAI JIAOTONG (CN) | 2009-05-06 | — | — | CN | claimed |
| CN-101420053-A | Guanidinium type ionic liquid electrolyzing solution for lithium secondary cell | UNIV SHANGHAI JIAOTONG (CN) | 2009-04-29 | — | — | CN | claimed |
| US-20250205156-A1 | FORMULATION FOR TRANSDERMAL DELIVERY | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-06-26 | — | — | US | disclosed |
| CN-119212683-A | Formulations for transdermal delivery | 陶氏环球技术有限责任公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-108513577-B | Biomimetic synthetic rubber and method for controlling physical properties thereof through stereochemistry of main chain double bonds | 阿克伦大学 | 2021-07-20 | — | — | CN | disclosed |
| US-9464184-B2 | Container and composition for enhanced gas barrier properties | THE COCA-COLA COMPANY (US) | 2016-10-11 | — | — | US | disclosed |
| US-9359488-B2 | Pet container and compositions having enhanced mechanical properties and gas barrier properties and methods | THE COCA-COLA COMPANY (US) | 2016-06-07 | — | — | US | disclosed |
| US-20160023998-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | BEZWADA BIOMEDICAL LLC (US) | 2016-01-28 | — | — | US | disclosed |
| CN-1890434-A | Filler-containing paper and a method for the production of filler-containing paper | BASF AG (DE) | 2007-01-03 | — | — | CN | disclosed |
| CN-1738793-A | Compounds, compositions and methods | CYTOKINETICS INC (US) | 2006-02-22 | — | — | CN | disclosed |
| EP-0136899-B1 | AMORPHOUS SULFOPOLYESTERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-04-19 | — | — | EP | disclosed |
| EP-0136899-A2 | Amorphous sulfopolyesters | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-04-10 | — | — | EP | disclosed |
| US-4480085-A | Amorphous sulfopolyesters | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-10-30 | — | — | US | disclosed |
| US-4477447-A | ANTIBIOTIC, BACTERICIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160023998-A1 | HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS | SI, KDM8, APEH | NAAA 10/4885HTT 3638/4885DGKA 1239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.